OmniAb, Inc. (OABI)
NASDAQ: OABI · IEX Real-Time Price · USD
4.350
+0.220 (5.33%)
At close: Jul 11, 2024, 4:00 PM
4.240
-0.110 (-2.53%)
After-hours: Jul 11, 2024, 6:15 PM EDT

OmniAb Revenue

OmniAb had revenue of $21.05M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $3.80M. In the year 2023, OmniAb had annual revenue of $34.16M.

Revenue (ttm)
$21.05M
Revenue Growth
-68.29%
P/S Ratio
24.21
Revenue / Employee
$198,547
Employees
106
Market Cap
509.50M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.16M-24.91M-42.17%
Dec 31, 202259.08M24.33M70.02%
Dec 31, 202134.75M11.48M49.34%
Dec 31, 202023.27M4.95M27.02%
Dec 31, 201918.32M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
biote 187.32M
Avid Bioservices 139.91M
Quanterix 125.98M
Jin Medical International 19.82M
Allogene Therapeutics 65.00K
Revenue Rankings